The extracellular domain of the Coxsackievirus and adenovirus receptor is sufficient for virus attachment and entry, independent of the transmembrane and cytoplasmic domains.
No takes yet. Share an insight, caveat, or question.
Should not yet change clinical practice for viral gene delivery; leaves open CAR domain targeting for in vivo validation.
Wang et al. (1999) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: